Skip to main content
. 2022 Aug 18;8(1):26–33. doi: 10.1136/svn-2022-001653

Table 3.

Associations with LVH

Unadjusted Adjusted
OR (95% CI) P value OR (95% CI) P value
Age 1.03 (1.00 to 1.05) 0.038 1.01 (0.98 to 1.04) 0.724
Sex 1.07 (0.59 to 1.93) 0.828 0.98 (0.48 to 1.99) 0.957
Hypertension 0.81 (0.39 to 1.66) 0.561 0.93 (0.40 to 2.19) 0.872
Hyperlipidaemia 0.87 (0.49 to 1.58) 0.654 0.69 (0.33 to 1.44) 0.324
Diabetes 0.99 (0.44 to 2.24) 0.975 0.93 (0.36 to 2.42) 0.881
Coronary artery disease 1.50 (0.70 to 3.21) 0.293 1.17 (0.45 to 3.03) 0.752
Atrial fibrillation 2.10 (1.02 to 4.33) 0.044 1.72 (0.74 to 4.02) 0.210
Creatinine 2.22 (1.04 to 4.76) 0.040 2.20 (1.04 to 4.68) 0.040
CAA pattern 1.55 (0.82 to 2.94) 0.179 1.90 (0.78 to 4.66) 0.161
HTN-cSVD pattern 4.53 (2.32 to 8.83) <0.001 7.38 (2.84 to 19.20) <0.001
Mixed NHIM 2.06 (0.76 to 5.57) 0.157 4.45 (1.25 to 15.90) 0.019

This table shows univariate and multivariable associations between predictor variables and LVH.

CAA, cerebral amyloid angiopathy; HTN-cSVD, hypertensive cerebral small vessel disease; LVH, left ventricular hypertrophy; NHIM, non-haemorrhagic imaging markers.